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The novel and efficient synthesis of type 2 Lewis antigens is reported in this study.  The rationally 
designed lactosamine-3,2′-diol derivative with an orthogonal set of protecting groups is efficiently 
glycosylated with a benzyl protected 1-thio-L-fucoside donor in a unique regioselective manner to 
produce Lewis x (Lex) and Lewis y (Ley) derivatives in good yields.  These derivatives can be 
prepared not only exclusively but also synchronously by choosing the appropriate reaction temperature 
and donor-acceptor molar ratio.  The Lex derivatives are easily converted into sulfated or non-sulfated 
Lex bearing a terminal azido functionalized oligo-(ethyleneoxide) linker; the Ley derivative having the 
same linker can also be prepared, all of which can be further used for the chemical modification of 
other compounds and materials. 





Lewis antigens are well-known as glycan-based blood group antigens,1 which are classified as 
type 1 and type 2, depending on the disaccharide core structure.  Type 1 Lewis antigens, Lewis a 
and Lewis b, have a common backbone [→3Galβ(1→3) GlcNAcβ1→] and exist widely in the 
membrane of erythrocytes.  The type 2 core structure [→3Galβ(1→4) GlcNAcβ1→] is also found 
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in numerous glycoconjugates; however, the distribution of its fucosylated derivatives, Lewis x (Lex) 
and Lewis y (Ley), classified as type 2 Lewis antigens (T2-LAs), is limited to some epithelial cells 
and leukocytes.  Notably, T2-LAs are overexpressed in various tumor cells,2 and are thus frequently 
used as biomarkers for the diagnosis of cancer.  Furthermore, these T2-LAs are sometimes found in 
their sulfated form, which includes a 6-O-sulfo-GlcNAc residue.3  The Lex determinant also plays a 
critical role in various biological events such as inflammation, lymphocyte homing, and infection of 
pathogens.4  Thus, T2-LAs have attracted much attention as promising target compounds for cancer 
therapy as well as for the treatment of inflammation, infectious diseases, etc. 
In order to utilize T2-LAs and their derivatives as bioactive compounds, it is essential to 
establish versatile, widely applicable synthetic methods.  A large number of reports on the synthesis 
of Lewis antigens have been published to date;5 however, none of them have reported the use of 
common key intermediates to construct T2-LAs, including their sulfated form.  In the present study, 
we report the successful and rapid assembly of T2-LAs (3–5) via a refined disaccharide key 
intermediate 2, which can be readily prepared from lactulose 1 through the Heyns rearrangement 
method6 (Figure 1).  This method is very convenient to obtain useful 2-amino-2-deoxy sugars, 




Figure 1. Efficient synthesis of T2-LAs (3–5) via the refined orthogonally protected T2 disaccharide 
derivative 2 derived from lactulose 1. 
 
2. Results and discussion 
2.1 Refinement of the molecular design of key intermediate 2 
In a previous paper,8 we reported the synthesis of T2-LAs having a set of orthogonal protecting 
groups via the useful disaccharide intermediate 2′ (Figure 2).  Compound 2′ was found to be an 
excellent intermediate for the synthesis of T2-LAs, but had a major drawback concerning the 
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removal of the anomeric 4-methoxyphenyl (PMP) group: the 6-O-tert-butyldimethylsilyl (TBDMS) 
group was found to be labile under oxidation conditions by cerium(IV) ammonium nitrate (CAN).  
It is acceptable to produce neutral, non-sulfated T2-LAs; however, in order to synthesize structurally 
complicated and highly bioactive sulfated T2-LAs, the protecting group at glucosamine C6 must be 
stable under oxidation conditions.  Thus, we refined the molecular design from 2′ to 2: the stability 
of the tert-butyldiphenylsilyl (TBDPS) group is several hundred times higher than that of TBDMS 
under acidic conditions, whereas both show similar susceptibility to tetra-n-butylammonium fluoride 
(TBAF).9  Therefore, TBDPS was selected as a more suitable protecting group for the C6 position 
of the glucosamine residue.  Further, the 4,6-O-benzylidene protecting group for the Gal residue 
was replaced with the p-methoxybenzylidene group, which is more rapidly removed by 
hydrogenolysis. 
 
Figure 2. Refinement of the molecular design of key intermediate 2. 
 
According to our previous report,8 the lactosamine derivative of 6 was readily prepared from 
lactulose 1 via the Heyns rearrangement (Scheme 1).  After removal of the acetyl protecting groups 
in 6, the 4′- and 6′-hydroxy moieties were protected with a p-methoxybenzylidene group to afford 7 
in 69% yield via a two-step procedure.  The 6-OH moiety in 7 reacted selectively with TBDPS-Cl 
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in pyridine, giving 8 in moderate yield (59%).  We originally controlled the selectivity in the 
regioselective 3′-O-benzoylation by lowering the reaction temperature (−50 °C). However, the 
unfavorable 3,3′-di-O-benzoyl product was formed even under the optimized conditions designed to 
obtain the target 3′-mono-O-benzoyl product.  In the present study, we exclusively obtained the 
target product 2 at ambient temperature in 73% yield by employing a metal-coordinated regio- and 
chemoselective nucleophilic substitution method.10 
 
Scheme 1. Reagents and conditions: (a) 1) MeONa / MeOH, 2) p-anisaldehyde dimethylacetal, (±)-
10-camphorsulfonic acid/DMF, 30 °C, 24 h, 69% (2 steps); (b) TBDPS-Cl/pyridine, rt, 64 h, 59%; 





2.2 On demand synthesis of Lex and Ley derivatives by regioselective α-fucosylation of 2 
Glycosylation of 2 with benzyl-protected phenyl 1-thio-L-fucopyranoside (9)11 is the extremely 
unique reaction throughout the synthesis of T2-LAs (Scheme 2).  In order to obtain the Lex 
derivative 10, the glycosylation was carried out at lower temperature (−78 °C) with a slight excess of 
9 over 2; under these conditions, 10 was isolated as the sole product in 76% yield (Table 1, entry 1).  
Ley derivative 11 was exclusively formed in 83% yield when more than twice the amount of 9 (2.4 
eq) relative to 2 was used at a higher temperature of −40 °C (entry 2).  The synchronous synthesis 
of 10 and 11 using 9 and 2 (entries 3 and 4) is worth mentioning. Compound 11 appeared at a higher 
temperatures (−40 °C or −50 °C) than that in entry 1.  Furthermore, both 10 and 11 were obtained 
efficiently in 49% and 45% yields, respectively, using an excess amount of 9 (1.8 eq) at −40 °C 
(entry 4).  These results indicate that the synthesis of 10 and 11 can be finely controlled by varying 
the reaction temperature and the feed ratio.  Notably, compounds 10 and 11 can be easily separated 
by conventional silica gel column chromatography: the Rf values for 10 and 11 in an n-hexane–




Scheme 2. On demand and synchronous syntheses of Lex and Ley derivatives via glycosylation of 2 
with 9 under the reaction conditions summarized in Table 1.  
 
Table 1. One-pot synthesis of 10 and 11 under different reaction conditions.a 
entry path 2/eq 9/eq NIS/eq TfOH/eq T/°C time/hb yield/% 
        10 11 
1 a 1.0 1.2 2.5 0.2 −78 1.0 76 n.d.c 
2 b 1.0 2.4 5.0 0.4 −40 3.0 n.d.c 83 
3 c 1.0 1.2 2.5 0.2 −50 2.0 25 16 
4 c 1.0 1.8 2.5 0.2 −40 1.0 49 45 
aReaction was carried out under the indicated conditions, in CH2Cl2–Et2O using the NIS–TfOH 
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activation system. bTime for complete consumption of 9. cNot detected. 
 
It is very intriguing that the reactivity of the two hydroxy groups in 2 is strictly fixed as 3-OH > 
2′-OH: a mono-fucosylated product at 2′-OH, that is, a type 2H 
[Fucα(1→2)Galβ(1→4)GlcNAcβ1→] derivative is not formed at all in this series of reactions.  
These results are consistent with our previous report,8 although the molecular design of acceptor 2 is 
slightly different from that of 2′.  Thus, the combination of the newly designed diol acceptor 2 and 
donor 9 has proved to be highly effective for not only the selective synthesis of Lex or Ley 
derivatives but also the synchronous synthesis of both derivatives in a one-pot reaction.  Although 
there are a few reports on lactosamine diol derivatives for the synthesis of T2-LAs,12 the order of 
reactivity of the two hydroxy groups in these derivatives is 2′-OH > 3-OH without exception, which 
is opposite to that for 2 and renders the preparation of Lex derivatives difficult.  Therefore, 
compound 2 is the most effective acceptor capable of providing both Lex and Ley derivatives when 
using 9 as the donor. 
 
2.3 Synthesis of 6-O-sulfo-Lex 3 and non-sulfated Lex 4 bearing a terminal azido functionalized 
oligo-ethyleneoxide linker 
For future applications of T2-LAs, we introduced a terminal azido functionalized aglycon 
moiety.  A highly hydrophilic oligo-(ethyleneoxide) structure is advantageous for conjugation with 
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all kinds of bioactive compounds such as proteins, lipids, polysaccharides, and synthetic polymers.  
Furthermore, azides are the first choice in current biochemical and materials sciences as they allow 
conjugation with a range of substances having alkyne groups via a Huisgen cycloaddition (“click 
chemistry” ).13,14  Hence, we selected a 2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl group as an 
efficient linker for T2-LAs, as shown in Fig. 1. 
Two types of Lex derivatives (3 and 4) were synthesized following the reactions outlined in 
Scheme 3. In order to avoid damaging the α-L-fucoside linkage and azido group, hydrogenation of 10 
was first carried out with Pd(OH)2 on activated carbon (Pd(OH)2-C) under H2 atmosphere.  This 
reaction normally proceeds to completion within 10 h, and the reaction mixture must be immediately 
worked-up, as prolonged reaction accelerates the undesirable cleavage of the α-L-fucoside linkage 
due to the acidity of the reagents.  After acetylation, compound 12 was obtained in 39% yield, in 
two steps.  Considering the low yield and our observations by TLC monitoring during the 
hydrogenation, removal of the benzyl protection in 11 without cleaving the α-L-fucoside linkage 
seems difficult. The anomeric PMP group of 12 was smoothly removed by CAN oxidation to 
produce 13 in 61% yield.  Compound 13 was converted into the activated glycosyl donor of 
trichloroacetimidate 14 through the reaction of trichloroacetonitrile with DBU in 83% yield.  The 
linker moiety was introduced through the glycosylation of 2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)-1-
ethanol with 14, promoted by the addition of TMSOTf at −50 °C, affording 15 in a modest yield of 
48%.  The acyl groups in 15 were removed successively by treatment with MeONa and hydrazine 
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monohydrate, followed by acetylation in pyridine and the removal of the TBDPS group with TBAF, 
affording 16 in 56% yield (4 steps).  Sulfation at the 6-OH group in 16 was carried out by the 
addition of SO3·NMe3 to produce 17 in excellent yield (91%).  Finally, all of the O-acetyl groups in 
17 were removed with MeONa, which resulted in the target 6-O-sulfo-Lex 3 in 63% yield.  The 
non-sulfated Lex derivative 4 was obtained from 15 through the reactions in steps e and h in 15% 
yield (5 steps). Thus, the sulfated and non-sulfated forms of the Lex derivatives were efficiently 
synthesized from a common intermediate, 10, which could be readily prepared through the 





Scheme 3. Reagents and conditions: (a) (1) Pd(OH)2-C, H2/MeOH, rt, 10 h, (2) Ac2O/pyridine, rt, 
overnight, 39% (2 steps); (b) CAN/CH3CN–H2O, 0 °C, 6 h, 61%; (c) CCl3CN, DBU/CH2Cl2, 0 °C, 5 
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h, 83%; (d) HO(CH2CH2O)3C2H4N3, TMSOTf, MS4A/CH2Cl2, −50 °C, 8 h, 48%; (e) (1) 
MeONa/MeOH, rt, overnight, (2) NH2NH2·H2O/EtOH, 90 °C, 7 h, (3) Ac2O/pyridine, rt, 48 h, (4) 
TBAF–AcOH/THF, rt, 72 h, 56% (4 steps); (f) SO3·NMe3/DMF, 55 °C, 72 h, 91%; (g) 
MeONa/MeOH, rt, overnight, 63%; (h) MeONa/MeOH, rt, overnight, 15% (5 steps from 15). 
 
2.4 Synthesis of Ley bearing a terminal azido functionalized oligo-ethyleneoxide linker 5 
The Ley derivative bearing a terminal azido functionalized oligo-ethyleneoxide linker 5 was also 
prepared according to the reactions outlined in Scheme 4.  Compound 11 was treated with Pd(OH)2-
C in THF–MeOH (1:1) mixture under H2 atmosphere as described for the synthesis of 12.  The 
obtained mixture was subjected to acetylation to provide pure 18.  The anomeric PMP group in 18 
was removed by CAN oxidation, followed by trichloroacetimidation to give 19.  Glycosidation of 
19 with 2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)-1-ethanol, which is the same acceptor employed in 
the synthesis of 15, proceeded very smoothly with the addition of a catalytic amount of TMSOTf at 
−50 °C and gave 20 within 30 min in a very good yield of 80%.  Compound 20 was converted into 
21 through a three-step reaction, i.e., removal of the acetyl and benzoyl groups by MeONa, removal 
of the phthaloyl group by hydrazine monohydrate and acetylation, which gave 21 in 64% yield.  All 
the protecting groups in 21 were removed by successive treatment with TBAF in THF and MeONa 
in MeOH, which led to the target Ley derivative 5 in 57% yield via two steps.  Thus, the Ley 






Scheme 4. Reagents and conditions: (a) (1) Pd(OH)2-C, H2/THF–MeOH, rt, 10 h, (2) Ac2O, 
DMAP/pyridine, rt, 24 h, 68% (2 steps); (b) (1) CAN/CH3CN–H2O, rt, 2 h, (2) CCl3CN, 
DBU/CH2Cl2, 0 °C, 4 h, 56% (2 steps); (c) HO(CH2CH2O)3C2H4N3, TMSOTf, MS4A/CH2Cl2, 
−50 °C, 0.5 h, 80%; (d) (1) MeONa/MeOH, rt, 2 h, (2) NH2NH2·H2O/EtOH, 90 °C, 13 h, (3) 
Ac2O/pyridine, rt, overnight, 64% (3 steps); (e) (1) TBAF/THF, rt, 72 h, (2) MeONa/MeOH, rt, 
overnight, 57% (2 steps). 
 
3. Conclusion 
In the present study, we have demonstrated for the first time the feasibility of the on-demand 
synthesis of Lex and Ley derivatives, in addition to their synchronous synthesis in one-pot through 
the combined use of diol acceptor 2 and benzyl-protected thiophenyl fucoside donor 9.  The 
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selectivity was easily controlled by varying the reaction temperature and the ratio of 2 and 9.  The 
derivatives of Lex and Ley were further functionalized by introducing an oligo-ethyleneoxide-azide 
linker through glycosylation.  The versatile set of orthogonal protecting groups of the obtained Lex 
derivative 15 enabled the facile and regioselective synthesis of both sulfated Lex 3 and non-sulfated 
Lex 4.  Ley derivative 5 was also easily prepared from 11.  Thus, our method is highly efficient for 




4.1 General methods 
Anhydrous solvents were purchased from Wako Pure Chemical Industries, Ltd., and stored 
under Ar atmosphere prior to use.  Other chemicals were used without further purification unless 
otherwise stated.  Molecular sieves (MS) AW300 and 4A were powdered and activated over 100 °C 
under reduced pressure with P2O5 as desiccant prior to use.  Silica gel flash column chromatography 
was performed on Silica Gel 60, spherical, neutrality (Nacalai Tesque), or with a CombiFlash Rf 75 
Var (Teledyne Isco) on RediSep Rf Gold Normal Phase Silica columns.  The reactions were 
monitored by TLC (silica gel 60 F254, Merck) visualized by sprayed with a mixture of 
H3(PMo12O40)· n H2O (12.5 g) and Ce(SO4)2·nH2O (5 g) in 10% H2SO4 (500 mL) and colored by 
heating at 140 °C.  Glycosylation reactions at −50 °C or lower were performed on UCR-150 
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(Techno-sigma).  Optical rotations were measured with a P-1010 polarimeter (Jasco). 1H and 13C 
NMR were recorded on a DPX-400 spectrometer (Bruker).  Assignments were based on homo- and 
heteronuclear correlation measurements, and DEPT measurements.  High resolution mass 
spectrometry was carried out with JMS-HX110A spectrometer (Jeol, for FAB-MS) or Exactive 





Compound 68 (13.5 g, 16.2 mmol) in dry MeOH (250 mL) was treated with MeONa in MeOH (ca. 
28wt%, 2.4 mL) at 0 °C under dry atmosphere for 23 h.  The formed precipitate was filtered through 
filter paper, and washed with MeOH.  The filtrate was neutralized by addition of Dowex 50W-X8 
(H+ form), filtered through a cotton bed, and concentrated to dryness by vacuum pump overnight.  
The former precipitate and the latter residue were combined and dissolved in dry DMF (120 mL).  To 
a solution of the mixture was added p-anisaldehyde dimethylacetal (3.16 mL, 18.6 mmol) under acidic 
conditions in the presence of catalytic amount of (±)-10-camphorsulfonic acid.  After kept stirring at 
rt for 7 h, excess amount of Et3N was added to neutralize the reaction system.  The mixture was 
concentrated under diminished pressure, and coevaporated with toluene.  The residue was purified 
by silica gel column chromatography (CHCl3/MeOH, 20:1, v/v, containing 0.5% Et3N) to provide 7 
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(7.75 g, 11.1 mmol, 69 %) as a white solid. 
[]D23 −20.8 (c 0.64, CHCl3); mp 128–130 °C ; Rf 0.30 (CHCl3/MeOH, 10:1); 1H NMR (400 MHz, 
CD3OD, TMS): δ (ppm) 7.96–7.78 (m, 4H, NPhth), 7.47–6.72 (m, 8H, -C6H4-OMe×2), 5.70 (d, 1H, 
J1,2 8.5 Hz, H-1
I), 5.56 (s, 1H, CH of p-methoxybenzylidene), 4.55 (d, 1H, J1,2 7.5 Hz, H-1
II), 4.51 
(dd, 1H, J2,3 11.0, J3,4 8.5 Hz, H-3
I), 4.28 (dd, 1H, J1,2 8.6, J2,3 11.0 Hz, H-2
I), 4.24–4.06 (m, 3H, H-
4II, H-6IIa, H-6Ia), 4.06–3.93 (m, 2H, H-6IIb, H-6Ib), 3.84 (t, 1H, J3,4=J4,5=9.6 Hz, H-4I), 3.77 (s, 3H, 
OMe), 3.73–3.63 (m, 7H, H-5I, H-2II, H-3II, H-5II, OMe) ; 13C NMR (100 MHz, CDCl3): δ 168.23, 
167.93 (C=O), 159.89, 155.21, 150.79, 134.03, 131.58, 130.38, 127.76, 123.32, 118.32, 114.32, 
113.30 (aromatic), 103.99 (C1II), 100.92 (CH of p-methoxybenzylidene ), 97.45 (C1I), 81.92 (C4I), 
75.53 (C4II), 75.05 (C5I), 72.08 (C3II), 70.58 (C2II), 69.70 (C3I), 68.73 (C6II), 66.82 (C5II), 61.54 
(C6I), 56.07 (C2I), 55.47, 55.17 (OMe); HRMS (FAB, positive ion mode, NBA) m/z = 718.2103 [M 




To a solution of 7 (7.75 g, 11.1 mmol) in anhydrous pyridine (120 mL) was added tert-
butyldiphenylchlorosilane (5.36 mL, 20.9 mmol) at rt under dry atmosphere.  After stirring for 64 h, 
MeOH was added to quench excess reagent, and then the mixture was concentrated under reduced 
pressure.  The residue was coevaporated with toluene and extracted with CHCl3, washed 
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successively with satd aq NaHCO3 and brine.  The organic layer was dried over MgSO4, filtered 
through a Celite bed and concentrated under diminished pressure.  The residue was subjected to 
silica gel column chromatography eluting with CHCl3/EtOAc (2:1, v/v, containing 0.1% Et3N) to 
provide pure 8 (6.12 g, 6.55 mmol, 59 %) as an amorphous powder. 
 [α]D23 −20.6 (c 1.0, CHCl3) ; Rf 0.33 (CHCl3/EtOAc, 1:1), 1H NMR (400 MHz, CDCl3, TMS): δ 
7.96–6.68 (m, 22H, NPhth, -OSiPh2CMe3 , -C6H4OMe×2), 5.75 (d, 1H, J1,2 8.0 Hz, H-1I), 5.45 (s, 
1H, CH of 4-methoxybenzylidene), 4.55 (dd, 1H, J2,3 10.5, J3,4 8.04 Hz, H-3
I), 4.50 (d, 1H, J1,2 8.0 
Hz, H-1II), 4.44 (dd, 1H, J1,2 8.5, J2,3 11.0 Hz, H-2
I), 4.30–4.22 (m, 2H, H-6IIa, 3I-OH), 4.17 (d, 1H, 
J3,4 3.0 Hz, H-4
II), 4.14–4.08 (m, 1H, H-6Ia), 4.06–3.97 (m, 2H, H-6Ib, H-6IIb), 3.86 (t, 1H, J3,4 = J4,5 
= 9.5 Hz, H-4I), 3.79 (s, 3H, OMe), 3.76–3.67 (m, 5H, H-5I, H-2II, OMe), 3.59 (ddd, 1H, J2,3 9.5, 
J3,OH 9.5, J3,4 3.5 Hz, H-3
II), 3.49 (bs, 1H, H-5II), 2.44 (d, 1H, J3,OH 9.5 Hz, 3
II-OH), 2.34 (d, 1H, J2,OH 
2.5 Hz, 2II-OH), 1.08 (s, 9H, Me3 of tert-Bu); 
13C NMR (100 MHz, CDCl3): δ 168.51, 168.04 (C=O), 
160.11, 155.33, 150.98, 149.54, 136.20, 135.84, 135.65, 134.09, 133.49, 132.78, 131.70, 130.04, 
129.68, 127.76, 127.66, 123.81, 118.80, 114.39, 113.49 (aromatic), 103.73 (C1II), 101.17 (CH of 4-
methoxybenzylidene ), 97.42 (C1I), 81.06 (C4I), 75.32 (C3II), 75.09 (C4II), 72.81 (C5I), 71.19 (C2II), 
69.75 (C3I), 68.67 (C6II), 66.93 (C5II), 62.41 (C6I), 56.37 (C2I), 55.61, 55.22 (OMe), 26.81 (CMe3 of 
tert-Bu), 19.36 (CMe3 of tert-Bu); HRMS (FAB, positive ion mode, NBA) m/z = 956.3308 [M + 






To a solution of compound 8 (2.40 g, 2.57 mmol) in dry THF (50 mL) was added Bu2SnCl2 (78.1 
mg, 0.26 mmol) and 1,2,2,6,6-pentamethylpiperidine (0.92 mL, 5.14 mmol), followed by kept 
stirring for 10 min at rt under Ar atmosphere.  Benzoyl chloride (0.36 mL, 2.57 mmol) was added 
dropwise to the mixture at rt under Ar atmosphere.  After stirring for 48 h, MeOH was added to 
quench excess reagent, and the mixture was evaporated under reduced pressure.  The residue was 
diluted with CHCl3, and washed with satd aq NaHCO3 and brine.  The organic layer was dried over 
MgSO4, filtered through a Celite bed, and concentrated under reduced pressure.  The residue was 
purified by silica gel column chromatography (CHCl3/EtOAc, 1:0 to 0:1, v/v, linear gradient) to 
afford 2 (1.95 g, 1.88 mmol, 73%) as colorless amorphous. 
[α]D23 +23.9 (c 1.0, CHCl3); Rf 0.41 (n-hexane/EtOAc, 1:1); 1H NMR (400 MHz, CDCl3, TMS): δ 
8.13–6.69 (m, 27H, aromatic), 5.75 (d,1H, J1,2 8.0 Hz, H-1I), 5.41 (s, 1H, CH of 4-
methoxybenzylidene), 5.01 (dd, 1H, J2,3 10.0, J3,4 3.5 Hz, H-3
II), 4.60 (d, 1H, J1,2 7.6 Hz, H-1
II), 4.54 
(t, 1H, J2,3 = J3,4 = 8.6 Hz, H-3
I), 4.50–4.41 (m, 2H, H-2I, H-4II), 4.27 (m, 1H, H-6IIa), 4.23 (s, 1H, 3I-
OH), 4.14–3.98 (m, 4H, H-2II, H-6Ia, H-6Ib, H-6IIb), 3.86 (t, 1H, J3,4 = J4,5 = 8.5 Hz, H-4I) 3.82–3.70 
(m, 7H, H-5I, OMe×2), 3.59 (s, 1H, H-5II), 2.17 (d, 1H, J2,OH 4.0 Hz, 2
II-OH), 1.09 (s, 9H, Me3 of 
tert-Bu); 13C NMR (100 MHz, CDCl3): δ 168.55, 168.13, 166.45 (C=O), 160.03, 155.39, 151.03, 
135.94, 135.69, 134.16, 133.48, 133.35, 132.85, 131.79, 130.16, 129.98, 129.83, 129.77, 129.65, 
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128.53, 127.87, 127.73, 127.53, 123.67, 123.41, 118.80, 114.44, 113.49 (aromatic), 104.03 (C1II), 
100.73 (CH of 4-methoxybenzylidene ), 97.48 (C1I), 81.94 (C4I), 75.40 (C5I), 74.25 (C3II), 73.31 
(C4II), 69.87 (C3I), 68.69 (C2II), 68.56 (C6II), 66.81 (C5II), 62.79 (C6I), 56.24 (C2I), 55.66, 55.29 
(OMe), 26.88 (CMe3 of tert-Bu), 19.38 (CMe3 of tert-Bu) ; HRMS (FAB, positive ion mode, NBA) 





Compound 2 (817 mg, 787 μmol) was added to a solution of 9 (497 mg, 944 μmol) in anhydrous 
CH2Cl2 (10 mL), and then diluted with anhydrous Et2O (20 mL).  The mixture was kept stirring at rt 
for 30 min under Ar atmosphere in the presence of activated powdered molecular sieves (MS) AW 
300 (1.00 g).  N-Iodosuccinimide (443 mg, 1.97 mmol) was added to the mixture, followed by 
cooling down to −78 °C under Ar atmosphere.  Triflic acid (13.8 μL, 141 μmol) in anhydrous Et2O 
(124 μL) was added dropwise to the mixture.  After stirring for 1 h, excess amount of Et3N was 
added to terminate the reaction.  After kept stirring for 15 min, the mixture was filtered through a 
bed of Celite, diluted with CHCl3, washed successively with 5 wt% aq Na2S2O3, satd aq NaHCO3 
and brine.  The organic layer was dried over MgSO4, filtered through a bed of Celite, and 
concentrated under reduced pressure.  The residue was subjected to silica gel column 
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chromatography (n-hexane/EtOAc, 2:1, v/v, containing 0.1% Et3N), providing pure 10 (867 mg, 596 
μmol, 76%) as a white solid. 
[α]D23 −10.2 (c 0.64, CHCl3); mp 106–107 °C; Rf 0.28 (n-hexane/EtOAc, 2:1); 1H NMR (400 MHz, 
CDCl3, TMS): δ 8.20–6.64 (m, 42H, aromatic), 5.55 (d, 1H, J1,2 8.5 Hz, H-1I), 5.52 (s, 1H, CH of 4-
methoxybenzylidene), 5.13–5.07 (m, 2H, H-1III, H-3III), 4.91–4.84 (m, 2H, H-3I, H-5II), 4.76–4.69 
(m, 2H, H-2I, H-1II), 4.61 (s, 2H, -CH2Ph), 4.53–4.25 (m, 6H, H-4I, H-6Ia, H-4III, H-6IIIa, -CH2Ph), 
4.19–4.10 (m, 2H, H-2III, -CH2Ph), 4.10–3.96 (m, 3H, H-6Ib, H-6IIIb, H-3II), 3.71 (s, 3H, OMe), 
3.69–3.62 (m, 2H, H-5I, H-2II), 3.59–3.48 (m, 4H, OMe, -CH2Ph), 3.42 (s, 1H, H-5III), 3.21 (s, 1H, 
H-4II), 2.38 (d, 1H, J2,OH 3.0 Hz, 2
III-OH), 1.13 (s, 9H, Me3 of tert-Bu), 1.08 (d, 3H, H-6
II, J5,6 6.5 
Hz); 13C NMR (100 MHz, CDCl3): δ 171.28, 166.35 (C=O), 159.96, 155.37, 151.18, 139.56, 139.48, 
138.16, 136.11, 135.44, 134.29, 133.88, 133.53, 132.29, 130.28, 130.00, 129.96, 129.80, 128.63, 
128.57, 128.39, 128.29, 128.23, 128.17, 128.05, 127.98, 127.93, 127.85, 127.78, 127.66, 127.46, 
127.39, 127.25, 127.12, 127.07, 127.02, 126.78, 123.76, 118.83, 114.44, 113.39 (aromatic), 101.78 
(C1III), 99.72 (CH of 4-methoxybenzylidene ), 98.19 (C1II), 97.89 (C1I), 79.14 (C3II), 78.77 (C4II), 
76.00 (C2II), 74.90 (CH2Ph), 74.61 (C4
I), 74.36 (C3III), 73.64 (C4III), 73.42 (C5I), 73.01 (CH2Ph), 
72.41 (C3I), 71.47 (CH2Ph), 69.63 (C2
III), 69.08 (C6III), 66.63 (C5III), 66.45 (C5II), 61.79 (C6I), 56.81 
(C2I), 55.70, 55.06 (OMe), 26.99 ( Me3 of tert-Bu), 19.74 (CMe3 of tert-Bu), 16.63 (C6
II) ; HRMS 







Compound 2 (2.01 g, 1.94 mmol) was added to a solution of 9 (2.45 g, 4.66 mmol) in anhydrous 
CH2Cl2 (15 mL), and then diluted with anhydrous Et2O (30 mL).  The mixture was kept stirring at rt 
for 30 min under Ar atmosphere in the presence of activated powdered MS AW 300 (2.0 g).  N-
Iodosuccinimide (2.18 g, 9.70 mmol) was added to the mixture, and then it was cooled down to −40 °C 
under Ar atmosphere.  Triflic acid (68 μL, 776 μmol) in anhydrous Et2O was injected to the mixture.  
After stirring for 3 h, excess amount of Et3N was added to terminate the reaction.  The mixture was 
filtered through a bed of Celite, diluted with CHCl3, washed successively with 5 wt% aq Na2S2O3, satd 
aq NaHCO3 and brine.  The organic layer was dried over MgSO4, filtered through a Celite bed, and 
concentrated under reduced pressure.  The residue was subjected to silica gel column 
chromatography (n-hexane/EtOAc, 1:0 to 0:1, v/v, linear gradient), providing pure 11 (3.03 g, 1.61 
mmol, 83%) as a white solid. 
[α]D −28.2 (c 0.54, CHCl3); mp 90–91 °C; Rf 0.79 (n-hexane/EtOAc, 1:1); 1H NMR (400 MHz, 
CDCl3, TMS): δ 8.10–6.68 (57H, m, aromatic), 5.57 (1H, d, J1,2 3.6 Hz, H-1III), 5.46 (1H, s, -CH of 
p-methoxybenzylidene), 5.42 (1H, d, J1,2 8.0 Hz, H-1
I), 5.18 (1H, d, J1,2 8.0 Hz, H-1
II), 5.13 (1H, dd, 
J2,3 10.0, J3,4 3.8 Hz, H-3
II), 4.98 (1H, d, Jgem 11.8 Hz, -CH2Ph), 4.91 (1H, m, H-5
IV), 4.75–4.73 (2H, 
m, H-2I, H-3I), 4.67 (1H, d, J1,2 4.0 Hz, H-1




I), 4.45–4.29 (7H, m, H-4II, H-2II, H-6IIb, -CH2Ph×4), 4.21 (1H, m, H-5III), 4.16 
(1H, m, H-6Ia), 4.05–3.98 (4H, m, H-6IIa, H-2III, H-3IV, -CH2Ph), 3.76 (3H, s, OMe), 3.71–3.65 (2H, 
m, H-6Ib, H-2IV), 3.55–3.52 (4H, m, OMe, H-3III), 3.45 (1H, d, J3,4 3.2 Hz, H-4III), 3.43 (1H, d, Jgem 
12.4 Hz, -CH2Ph), 3.33 (1H, m, H-5
II), 3.20 (1H, m, H-5I), 3.09 (1H, s, H-4IV), 1.30 (1H, d, J5,6 7.2 
Hz, H-6III), 1.19 (1H, d, J5,6 6.4 Hz, H-6
IV), 1.11 (9H, s, Me3 of tert-Bu);
 13C NMR (100 MHz, 
CDCl3): δ 165.61, 159.97, 155.59, 151.32, 139.74, 139.57, 138.95, 138.78, 138.45, 138.19, 136.06, 
135.15, 133.093, 133.71, 132.32, 130.18, 130.09, 129.94, 129.89, 129.70, 128.88, 128.46, 128.39, 
128.33, 128.30, 128.27, 128.21, 128.18, 128.11, 128.04, 127.93, 127.82, 127.71, 127.57, 127.44, 
127.37, 127.34, 127.10, 127.08, 127.05, 126.97, 126.65, 119.18, 114.45, 113.43 (C=O, aromatic), 
99.86 (C1II), 99.83 (CH of p-methoxybenzylidene ), 98.75 (C1IV), 98.41 (C1I), 98.36 (C1III), 79.48 
(C4III), 79.38 (C3IV), 78.73 (C4IV), 77.96 (C3III), 77.55 (C4I), 76.61 (C2III), 76.16 (C3II), 75.99 (C5I), 
75.07, 74.73 (CH2Ph), 73.30 (C4
II), 73.28 (CH2Ph), 73.09 (CH2Ph), 72.94 (C3
I, CH2Ph), 72.83 
(C2IV), 72.31 (C2II), 71.38 (CH2Ph), 69.14 (C6
II), 67.51 (C5III), 66.84 (C5IV), 66.33 (C5II), 61.47 
(C6I), 56.92 (C2I), 55.84, 55.10 (OMe), 26.87 (Me3 of tert-Bu), 19.74 (CMe3 of tert-Bu), 16.39 








Compound 10 (0.43 g, 294 μmol) was dissolved in the mixture of dry MeOH (4.0 mL) and dry THF 
(4.0 mL) followed by addition of Pd(OH)2 on activated carbon (20%, 200 mg).  After stirring at rt 
under H2 atmosphere for 10 h, the mixture was filtered through filter paper, followed by concentration 
under reduced pressure.  To a solution of the residue in pyridine (8 mL) was added Ac2O (350 μL, 
3.70 mmol) under dry atmosphere at rt overnight, and methanol was added to quench excess reagents.  
The mixture was concentrated and coevaporated with toluene under reduced pressure.  The residue 
was dissolved in CHCl3, and washed with satd aq NaHCO3 and brine.  The organic layer was dried 
over MgSO4, filtered through a Celite bed, and concentrated under reduced pressure.  The residue 
was purified by silica gel column chromatography (Rf 75 system, n-hexane/EtOAc, 1:0 to 0:1, v/v, 
linear gradient) to afford 12 (153 mg, 116 μmol, 39%) as colorless amorphous. 
[α]D30 −42.7 (c 0.05, CHCl3 ); Rf 0.32 (n-hexane/EtOAc, 1:1); 1H NMR (CDCl3, 400 MHz, TMS): δ 
7.95–6.69 (23H, m, aromatic), 5.60 (d, 1H, J3,4 3.2 Hz, H-4III), 5.55 (d, 1H, J1,2 8.4 Hz, H-1I), 5.42 (s, 
1H, H-4III), 5.29–5.02 (m, 5H, H-3II, H-5II, H-1III, H-2III, H-3III), 4.98 (d, 1H, J1,2 4.0 Hz, H-1II), 
4.87–4.82 (m, 2H, H-3I, H-2II), 4.58–4.51 (m, 2H, H-2I, H-6IIIa), 4.37–4.30 (m, 2H, H-4I, H-6IIIb), 
3.91–3.84 (m, 1H, H-5I), 3.73 (s, 3H, OMe), 3.53 (bd, 1H, J5,6 10.0 Hz, H-5III), 2.14–1.80 (m, 18H, 
Ac), 1.27 (d, 3H, J5,6 6.0 Hz, H-6
II), 1.12 (s, 9H, Me3 of tert-Bu); 
13C NMR (CDCl3, 100 MHz): δ 
170.87, 170.73, 170.48, 170.42, 169.80, 169.05, 165.32 (C=O), 155.57, 150.98, 136.13, 135.89, 
134.56, 133.60, 130.25, 130.04, 129.94, 128.70, 128.23, 128.15, 127.84, 123.81, 118.83, 114.54 
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(aromatic), 99.92 (C1III), 97.74 (C1I), 95.45 (C1II), 75.56 (C5I), 74.17 (C4I), 72.00 (C3III), 71.60 
(C4II), 71.48 (C3I), 71.36 (C5III), 69.35 (C2III), 68.30 (C3II), 67.94 (C2II), 67.07 (C4III), 64.37 (C5II), 
61.19 (C6I), 61.10 (C6III), 56.60 (C2I), 55.74 (OMe), 27.01 (Me3 of tert-Bu), 20.95, 20.87, 20.81, 
20.67, 20.62 (Ac), 19.46 (CMe3 of tert-Bu), 16.10 (C6
II); HRMS (ESI, positive ion mode) m/z = 




Compound 12 (153 mg, 116 μmol) was dissolved in a mixed solution of CH3CN-H2O (8.0 mL – 2.0 
mL) followed by addition of cerium(IV) ammonium nitrate (CAN) (190 mg, 348μmol).  After stirring 
at rt for 6 h, the mixture was concentrated under reduced pressure to remove CH3CN.  The residue 
was dissolved in CHCl3, washed successively with satd aq NaHCO3 and brine.  The organic layer 
was dried over MgSO4, filtered through a Celite bed, and concentrated under reduced pressure.  The 
residue was purified by silica gel column chromatography eluting with CH3Cl/EtOAc (1:0 to 0:1, v/v, 
linear gradient, Rf 75 system) to afford 13 (86 mg, 70.9 μmol, 61%) as a yellowish amorphous powder.  
[α]D28 −22.2 (c 0.1, CHCl3 ); Rf 0.56 (CH3Cl/EtOAc, 2:1); 1H NMR (CDCl3, 400 MHz, TMS): δ 
7.94–7.41 (19H, m, aromatic), 5.58 (d, 1H, J3,4 3.2 Hz, H-4III), 5.39 (d, 1H, J3,4 3.2 Hz, H-4 II), 5.29–
5.16 (m, 3H, H-1I, H-3II, H-2III), 5.13–5.00 (m, 3H, H-1III, H-5II, ), 5.03 (dd, 1H, J2,3 10.0, J3,4 10.0 
Hz, H-3III), 4.95 (d, 1H, J1,2




 11.2 Hz, H-6IIIa), 4.33–4.10 (m, 3H, H-4I, H-6IIIb, H-2I), 4.04 (m, 2H, H-6Ia, H-6Ib), 3.84–3.79 
(m, 1H, H-5III), 3.47 (m, 1H, H-5I), 2.66 (d, 1H, J1,OH 8.2 Hz, 1-OH), 2.13–1.85 (m, 18H, Ac), 1.25 
(d, 3H, J5,6 6.0 Hz, H-6
II), 11.5 (s, 9H, CMe3 of tert-Bu); 
13C NMR (CDCl3, 100 MHz): δ 170.89, 
170.77, 170.48, 170.27, 169.82, 169.12, 165.35 (C=O), 136.26, 135.61, 134.55, 133.62, 133.45, 
132.46, 130.34, 130.12, 129.77, 129.15, 128.73, 128.21, 127.89, 123.77 (aromatic), 99.86 (C1III), 
95.30 (C1II), 92.86 (C1I), 75.79 (C5I), 74.19 (C4I), 72.04 (C3 III), 71.64 (C4II), 71.26 (C5III, C3I), 
69.36 (C2III), 68.28 (C3II), 68.05 (C2II), 67.02 (C4III), 64.37 (C5II), 61.37 (C6I), 61.09 (C6III), 58.58 
(C2I), 27.12 (CMe3 of tert-Bu), 20.99, 20.92, 20.84, 20.73, 20.71, 20.65 (Ac), 19.55 (CMe3 of tert-






To a solution of compound 13 (32 mg, 26.4 μmol) in dry CH2Cl2 (5.0 mL) was added 
trichloroacetonitrile (53 μL, 527 μmol). After stirring at 0 oC under Ar atmosphere for 30 min, DBU 
(1 μL, 7.9 μmol) was added, then the reaction mixture was kept stirring at 0 oC under Ar atmosphere 
for 5 h.  The mixture was evaporated under reduced pressure.  The residue was purified by silica gel 
column chromatography (n-hexane-ethyl acetate containing 0.5% Et3N, 1:0 to 0:1, v/v, linear gradient, 
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Rf 75 system) to afford 14 (30 mg, 22.1 μmol, 83%) as colorless amorphous.  
[α]D27 −42.7 (C 0.1, CHCl3 ); Rf 0.41 (n-hexane/EtOAc 1:1 containing with Et3N); 1H NMR (CDCl3, 
400 MHz, TMS): δ 8.55 (s, 1H, -CNHCCl3), 7.96–7.30 (m,19H, aromatic), 6.36 (d, 1H, J1,2 8.8 Hz, 
H-1I), 5.60 (d, 1H, J3,4 3.2 Hz, H-4
III), 5.42 (d, 1H, J3,4 2.8 Hz, H-4
 II), 5.31 (dd, 1H, J1,2 10, J2,3 10 
Hz, H-2III), 5.24–5.19 (m, 2H, H-1III, H-3II), 5.16–5.12 (m, 2H, H-3III, H-5II), 5.01 (d, 1H, J1,2 4.0 Hz, 
H-1II), 4.91 (t, 1H, J2,3
 =J3,4=8.7 Hz, H-3
I), 4.82 (dd, 1H, J1,2 3.9, J2,3
 10.9 Hz, H-2II), 4.65–4.52 (m, 
2H, H-2I, H-6IIIa), 4.40–4.31 (m, 2H, H-4I, H-6IIIb), 4.08 (bs, 2H, H-6Ia, H-6Ib), 3.86 (m, 1H, H-5III), 
3.66–3.60 (m, 1H, H-5I), 2.13, 2.12, 2.09, 2.08, 1.93, 1.84 (s×6, 18H, Ac), 1.28 (d, 3H J5,6 6.4 Hz, H-
6II), 1.15 (s, 9H, Me3 of tert-Bu); 
13C NMR (CDCl3, 100 MHz): δ 170.86, 170.82, 170.42, 170.21, 
169.77, 169.03, 165.30, 160.73 (C=O, -CNHCCl3), 136.14, 135.38, 134.59, 133.60, 133.47, 131.95, 
130.24, 130.02, 129.75, 128.69, 128.20, 127.80, 123.71 (aromatic), 99.95 (C1III), 95.39 (C1II), 93.62 
(C1I), 90.47 (-CCl3), 76.06 (C5
I), 73.95 (C4I), 71.98 (C3III), 71.56 (C4II), 71.43 (C5III), 71.20 (C3I), 
69.31 (C2III), 68.22 (C3II), 68.09 (C2II), 67.10 (C4III), 64.38 (C5II), 61.18 (C6III), 60.09 (C6I), 55.58 
(C2I), 26.98 (C(CH3)3 of tert-Bu), 20.95, 20.89, 20.81, 20.65, 20.61 (Ac), 19.55 (C(CH3)3 of tert-
Bu), 16.09 (C6II); HRMS (ESI, positive ion mode) m/z = 1377.2974 [M + Na]+, calcd for 







To a solution of compound 14 (40 mg, 29.8 μmol) in dry CH2Cl2 (5.0 mL) was added 2-(2-(2-(2-
azidoethoxy)ethoxy)ethoxy)ethanol (19 mg, 88.5 μmol) and activated 4Å molecular sieves (MS4A, 80 
mg).  After stirring at −50 oC under Ar atmosphere for 30 min, TMSOTf (2 μL, 8.85 μmol) was added 
to the mixture, followed by stirring at −50 oC under Ar atmosphere for 8 h.  After the reaction was 
completed, the reaction mixture was neutralized by addition of Et3N, filtered through a Celite bed, and 
the filtrate was concentrated under reduced pressure.  The residue was dissolved in CHCl3, and 
washed with satd aq NaHCO3 and brine.  The organic layer was dried over MgSO4, filtered through 
a Celite bed, and concentrated under reduced pressure.  The residue was purified by silica gel column 
chromatography (n-hexane/EtOAc 1:0 to 0:1, v/v, Rf 75 system, linear gradient) to afford 15 (20 mg, 
14.2 μmol, 48%) as colorless amorphous. 
[α]D29 −44.4 (c 0.1, CHCl3 ); Rf 0.31 (n-hexane/EtOAc 2:3); 1H NMR (CDCl3, 400 MHz, TMS): δ 
7.95–7.36 (m,19H, aromatic), 5.58 (d, 1H, J3,4 3.2 Hz, H-4III), 5.40 (d, 1H, J3,4 2.4 Hz, H-4II), 5.28 
(dd, 1H, J1,2 8.4, J2,3 10.0 Hz, H-2
III), 5.22–5.17 (m, 2H, H-1III, H-3II), 5.13–5.07 (m, 3H, H-1I, H-3III, 
H-5II), 4.95 (d, 1H, J1,2
 4.0 Hz, H-1II), 4.82 (dd, 1H, J1,2 4.0, J2,3
 10.9 Hz, H-2II), 4.77 (t, 1H, J2,3
 
=J3,4=9.9 Hz, H-3
I), 4.55 (dd, 1H, J5,6a 6.7, J6a,6b 11.6 Hz, H-6
IIIa), 4.35–4.22 (m, 3H, H-2I, H-4I, H-
6IIIb), 4.07–3.98 (m, 2H, H-6Ia, H-6Ib), 3.89–3.83 (m, 2H, H-5III, PEG), 3.65–3.25 (m, 16H, H-5I, 
PEG), 2.12, 2.10, 2.06, 1.91, 1.82 (s×6, 18H, Ac), 1.25 (d, 3H, J5,6
 6.4 Hz, H-6II), 1.15 (s, 9H, Me3 of 
tert-Bu); 13C NMR (CDCl3, 100 MHz): δ 170.91, 170.89, 170.51, 170.29, 169.83, 169.12, 165.36 
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(C=O), 136.23, 135.50, 134.48, 133.62, 133.46, 132.25, 130.29, 130.07, 129.79, 129.16, 128.73, 
128.24, 127.85, 123.68 (aromatic) , 99.93 (C1III), 98.18(C1I), 95.36 (C1II), 75.44 (C5I), 74.38 (C4I), 
72.06 (C3III), 71.68 (C4II), 71.54 (C3I), 71.31 (C5III), 70.72, 70.64, 70.62, 70.54, 70.20, 70.16 (PEG), 
69.45 (C2III), 68.53 (PEG), 68.32 (C3II), 68.04 (C2II), 67.11 (C4III), 64.33 (C5II), 61.18 (C6I, C6III), 
56.71 (C2I), 50.79 (PEG), 27.07 (CMe3 of tert-Bu), 20.98, 20.95, 20.85, 20.71, 20.67 (Ac), 19.54 
(CMe3 of tert-Bu), 16.14 (C6
II); HRMS (ESI, positive ion mode) m/z = 1435.5026 [M + Na]+, calcd 





Compound 15 (51 mg, 36.8 μmol) was suspended in dry MeOH (5.0 mL) followed by the addition 
of ca. 28 wt-% MeONa in MeOH (3 μL, 19.7 μmol).  After stirring at rt under dry atmosphere 
overnight, the reaction mixture was neutralized by the addition of Dowex 50W-X4 (H+ form), filtered 
through cotton, and concentrated under reduced pressure.  The residue dissolved in EtOH (5.0 mL) 
was added NH2NH2·H2O (10 μL, 205.8 μmol).  After stirring at 90 °C for 7 h, reaction mixture was 
concentrated to dryness under reduced pressure.  The residue was dissolved in pyridine (5.0 mL) 
followed by addition of Ac2O (65 μL, 687.6 μmol) and DMAP (3 mg, 24.6 μmol).  After stirring at 
rt under dry atmosphere for 36 h, MeOH was added to quench excess reagents, followed by 
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concentration under reduced pressure.  The residue was dissolved in CHCl3, and washed with satd aq 
NaHCO3 and brine.  The organic layer was dried over MgSO4, filtered through a Celite bed, and 
concentrated under reduced pressure.  The residue was roughly purified by silica gel column 
chromatography eluting with CH3Cl/MeOH (1:0 to 6:1, v/v, Rf 75 system, linear gradient).  The 
obtained compound was dissolved in dry THF (3.0 mL) followed by the addition of AcOH (5 μl, 91.8 
μmol) and 1M TBAF in THF (207 μl, 207 μmol).  After stirring at rt under Ar atmosphere for 72 h, 
the reaction mixture was concentrated under reduced pressure and extracted with CHCl3, washed with 
satd aq NaHCO3 and brine.  The organic layer was dried over MgSO4, filtered through a Celite bed, 
and concentrated under reduced pressure.  The residue was purified by silica gel column 
chromatography eluting with CHCl3/MeOH (1:0 to 6:1, v/v, linear gradient, Rf 75 system) to afford 
the compound 16 (21 mg, 20.5 μmol, 56%, 4 steps) as colorless amorphous. 
[α]D26 −71.4 (c 0.2, CHCl3 ); Rf 0.24 (CHCl3/MeOH, 10:1); 1H NMR (CDCl3, 400 MHz, TMS): δ 
6.31 (d, 1H, J2,NHAc 9.4 Hz, NHAc), 5.42–5.38 (m, 3H, H-1II, H-4II, H-4III), 5.22 (dd, 1H J2,3 11.0, J3,4 
3.4 Hz, H-3II), 5.10–4.98 (m, 4H, H-2II, H-5II, H-2III, H-3III), 4.73 (d, 1H, J1,2 7.28 Hz, H-1III), 4.67 
(d, 1H, J1,2 8.40 Hz, H-1
I), 4.50 (dd, 1H, J5,6a 6.2, J6a,6b 11.4 Hz, H-6a
III), 4.32 (dd, 1H, J5,6b 7.9, J6a,6b 
11.4 Hz, H-6bIII), 4.03–3.90 (m, 4H, H-2I, H-4I, H-6Ia, H-5III), 3.85–3.54 (m, 16H, H-3I, H-6Ib, 
PEG), 3.45–3.39 (m, 2H, PEG), 3.28–3.24 (m, 1H, H-5I), 2.30 (dd, 1H, J6a,OH 3.96, J6Ib,OH 9.6 Hz, I6-
OH), 2.19, 2.14, 2.13, 2.08, 2.05, 1.98, 1.97, 1.95 (s×8, 24H, Ac), 1.19 (d, 3H J5,6 6.5 Hz, H-6
II); 13C 
NMR (CDCl3, 100 MHz): δ 171.70, 171.15, 170.87, 170.67, 170.64, 170.14, 169.79, 169.26 (C=O), 
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102.11 (C1I), 100.40 (C1III), 95.58(C1II), 75.45 (C5I), 74.55 (C4I), 73.76 (C5III), 71.73 (C4III, PEG), 
71.09, 71.05 (C3I, C3III), 70.99, 70.69, 70.67, 70.52, 70.10 (PEG), 69.47 (C2III), 68.59 (PEG), 68.11 
(C2II, C3II), 67.05 (C4II), 64.14 (C5II), 60.87 (C6I), 60.59 (C6III), 55.97 (C2I), 50.76 (PEG), 23.35, 
21.26, 20.96, 20.86, 20.83, 20.81, 20.76, 20.70 (Ac), 15.97 (C6II); HRMS (ESI, positive ion mode) 
m/z = 1047.3740 [M + Na]+, calcd for C42H64N4O25Na, 1047.3757. 
 
4.12. Triethylammonium {2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl 2,3,4,6-tetra-O-acetyl-β-
D-galactopyranosyl-(1→4)-[2,3,4-tri-O-acetyl-α-L-fucopyranosyl-(1→3)]-2-acetamido-2-deoxy-
6-O-sulfonato-β-D-glucopyranoside} (17). 
Compound 16 (28 mg, 27.3 μmol) was dissolved in dry DMF (3.0 mL) and Et3N (600 μL).  After 
stirring at 55 °C under Ar atmosphere for 20 min, the reaction mixture was added to SO3·NMe3 (145 
mg, 934 μmol).  After stirring at 55 °C for 72 h, MeOH (1 mL) was added to quench excess reagents, 
and evaporated under reduced pressure.  The residue was purified by LH-20 size exclusion column 
chromatography eluting with MeOH to afford 17 (30 mg, 24.9 μmol, 91%) as colorless amorphous.   
[α]D23 −83.8 (c 0.07, MeOH ); Rf 0.17 (CHCl3/MeOH 10:1); 1H NMR (400 MHz, CDCl3, TMS): δ 
9.46 (1H, bs, SO3H), 6.43 (d, 1H, J2,NHAc 9.6 Hz, NHAc), 5.45 (bs, 1H, H-4
III), 5.39 (d, 1H, J1,2 3.8 
Hz, H-1II), 5.36 (bd, 1H, J3,4 3.0 Hz, H-4
II), 5.26 (dd, 1H, J2,3 10.9, J3,4 3.3 Hz, H-3
II), 5.10–4.97 (m, 
5H, H-2II, H-3III, H-5II, H-1III, H-2III), 4.60 (d, 1H, J1,2 8.40 Hz, H-1
I), 4.44 (dd, 1H, J5,6a 5.8, J6a,6b 




3.93 (m, 3H, H-2I, H-5III, PEG), 3.80–3.54 (m, 14H, PEG), 3.47–3.42 (m, 4H, H-3I, H-4I, H-5I, 
PEG), 3.20 (6H, m, N(CH2CH3)3), 2.17, 2.14, 2.12, 2.08, 2.06, 1.96, 1.95, 1.94 (s×8, 24H, Ac), 1.40 
(t, 9H, J 7.3 Hz, N(CH2CH3)3), 1.20 (d, 3H, J5,6 6.5 Hz, H-6
II); 13C NMR (CDCl3, 100 MHz): δ 
171.60, 171.26, 170.83, 170.61, 169.83, 169.80, 169.79, 169.76 (C=O), 102.04 (C1I), 99.66 (C1III), 
95.53 (C1II), 74.63 (PEG), 73.79 (C3I, C5I), 73.43 (C5III), 71.83 (C4II), 71.65 (PEG), 71.29 (C3III), 
70.88 (PEG), 70.72 (C4I), 70.65, 70.61, 70.46, 70.06 (PEG), 69.44 (C2III), 68.47 (PEG), 68.20 (C2II), 
67.94 (C3II), 67.25 (C4III), 64.91 (C6I), 64.30 (C5II), 60.64 (C6III), 55.46 (C2I), 50.78 (PEG), 46.71 
(N(CH2CH3)3), 23.30, 21.22, 21.02×2, 20.88, 20.83, 20.77, 20.69 (Ac), 15.97 (C6
II), 8.83 






To a solution of compound 11 (1.00 g, 0.53 mmol) in 20.0 mL of THF–MeOH (1:1,v/v) was added 
Pd(OH)2-C (20%, 0.25 g, 1.78 mmol).  After stirring at rt under H2 for 10 h, the reaction mixture was 
filtered through a Celite bed, and the filtrate was concentrated under reduced pressure.  The residue 
was dissolved in dry pyridine (10.0 mL), followed by addition of DMAP (64 mg 0.53 mmol) and Ac2O 
(1.0 mL, 10.6 mmol).  After stirring at rt under dry atmosphere for 24 h, MeOH was added to quench 
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excess reagents, and then concentrated and coevaporated with toluene under reduced pressure.  The 
residue was dissolved in CHCl3, and washed with satd aq NaHCO3 and brine.  The organic layer was 
dried over MgSO4, filtered through a Celite bed, and concentrated under reduced pressure.  The 
residue was subjected to silica gel column chromatography eluting with n-hexane/EtOAc (1:2, v/v, 
containing 0.5% Et3N) to afford 18 (562 mg, 0.36 mmol, 68%) as colorless amorphous.  
[α]D27 −110.1 (c 0.03, CHCl3 ); Rf 0.63 (n-hexane/EtOAc, 1:2); 1H NMR (400 MHz, CDCl3, TMS): δ 
7.89–7.32, 7.23–6.74 (23H, m, aromatic), 5.51 (bd, 1H, J3,4 3.4 Hz, H-4II), 5.45 (d, 1H, J1,2 8.5 Hz, 
H-1I), 5.40 (bd, 1H, J3,4 2.7 Hz, H-4
III), 5.26–5.09 (7H, m, H-1IV, H-4IV, H-3III, H-3II, H-1II, H-2IV, H-
5II), 4.97–4.81 (m, 4H, H-1III, H-3IV, H-2III, H-3I), 4.59 (dd, 1H, J1,2 8.6, J2,3 10.0 Hz, H-2I), 4.53–
4 .40 (m, 3H, H-4I, H-6
IIa, H-5IV), 4.30 (dd, 1H, J5,6 7.4, J6a,6b 11.4 Hz, H-6
IIb), 4.23–4.15 (m, 2H, H-
6Ia, H-6Ib), 3.92 (bt, 1H, J1,2=J2,3=9.0 Hz, H-2
II), 3.85–3.80 (m, 1H, H-5II), 3.75 (s, 3H, OMe), 3.47–
3.43 (m, 1H, H-5I), 2.15, 2.11, 2.09, 2.08, 2.07, 1.92, 1.86, 1.72 (s×8, 24H, Ac), 1.27–1,24 (m, 6H, 
H-6III, H-6IV), 1.16 (s, 9H, Me3 of tert-Bu); 
13C NMR (CDCl3, 100 MHz): δ 171.00, 170.88, 170.67, 
170.40, 170.15, 169.88, 169.85, 169.61, 169.15 (C=O), 155.69, 1150.94, 135.99, 135.41, 134.55, 
133.90, 133.46, 132.04, 130.04, 129.99, 129.93, 129.96, 128.90, 128.27, 128.15, 127.89, 127.86 
(aromatic), 99.86 (C1II), 98.16 (C1I), 97.72 (C1IV), 95.92 (C1III), 75.42 (C5I), 74.21 (C2II), 74.07 
(C3II), 73.04 (C4I), 72.47 (C3I), 71.70 (C4III), 71.20 (C5II), 71.06 (C4IV), 68.23 (C3III), 67.98 (C3IV), 
67.67 (C2III), 67.27(C4II), 66.88 (C2IV), 65.41 (C5IV), 64.41 (C5III), 61.14, 61.08 (C6I, C6II), 56.83 
(C2I), 55.80 (OMe), 27.16 (Me3 of tert-Bu), 21.06, 20.97, 20.82, 20.73, 20.69×2, 20.67, 20.34 (Ac), 
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19.43 (CMe3 of tert-Bu), 15.59, 15.52 (C6
III, C6IV); HRMS (ESI, positive ion mode) m/z = 




butyldiphenylsilyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl trichloroacetimidate (19). 
Compound 18 (562 mg, 0.36 mmol) was dissolved in a mixed solution of CH3CN (8.0 mL)–H2O (2.0 
mL) followed by addition of CAN (592 mg, 1.08 mmol).  After stirring at rt for 2 h, the reaction 
mixture was extracted with CHCl3, washed successively with satd aq NaHCO3 and brine.  The 
organic layer was dried over MgSO4, filtered through a Celite bed, and concentrated under reduced 
pressure.  The residue was purified by silica gel column chromatography (CHCl3/MeOH, 30:1, 
containing 0.5% Et3N) to afford the corresponding anomer-free compound (440 mg).  To a solution 
of this compound (440 mg) in dry CH2Cl2 (10 mL) was added CCl3CN (290 μL, 2.90 mmol).  After 
stirring at 0 °C under Ar for 15 min, DBU (13 μL, 87 μmol) was added to the mixture.  After kept 
stirring for 4 h, the mixture was concentrated under reduced pressure.  The residue was purified by 
silica gel column chromatography (CHCl3/EtOAc, 3:1, containing 0.5% Et3N ) to afford 19 (314 mg, 
0.20 mmol, 2 steps, 56%) as colorless amorphous.  
[α]D27 −77.4 (c 0.5, CHCl3 ); Rf 0.57 (CHCl3/EtOAc 2:1); 1H NMR (400 MHz, CDCl3, TMS): δ 8.58 
(s, 1H, NH), 7.90–7.32 (19H, m, aromatic), 6.32 (d, 1H, J1,2 8.8 Hz, H-1I), 5.51 (bd, 1H, J3,4 3.6 Hz, 
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H-4II), 5.39 (bd, 1H, J3,4 2.8 Hz, H-4
III), 5.26–5.24 (m, 2H, H-1IV, H-4IV), 5.23–5.16 (m, 2H, H-3II, H-
3III), 5.14-5.07 (m, 3H, H-5III, H-1II, H-2IV), 5.02–4.95 (m, 2H, H-3IV, H-1III), 4.94–4.84 (m, 2H, H-3I, 
H-2III), 4.63 (dd, 1H, J1,2 8.9, J2,3 10.2 Hz, H-2
I), 4.53–4.44 (m, 2H, H-4I, H-6IIa), 4.42–4.36 (m, 1H, 
H-5IV), 4.33-4.18 (m, 3H, H-6Ia, H-6Ib, H-6IIb), 3.92 (dd, 1H, J1,2 8.1, J2,3 9.9 Hz, H-2
II), 3.80–3.75 
(m,1H, H-5II), 3.62–3.58 (m, 1H, H-5I), 2.12, 2.11, 2.09, 2.08, 2.07, 1.93, 1.86, 1.71 (s×8, 24H, Ac), 
1.28–1.24 (m, 6H, H-6III, H-6IV), 1.16 (s, 9H, CMe3 of tert-Bu); 13C NMR (CDCl3, 100 MHz): δ 170.97, 
170.86, 170.53, 170.38, 170.13, 169.86, 169.61, 168.05, 165.23, 160.74 (C=O), 136.03, 135.40, 
134.65, 133.87, 133.57, 132.19, 131.45, 130.09, 130.01, 129.57, 128.95, 128.72, 128.20, 127.88, 
123.72 (aromatic, C=NH), 100.01 (C1II), 97.80 (C1IV), 95.89 (C1III), 94.08 (C1I), 90.48 (CCl3), 76.03 
(C5I), 74.39 (C2II), 73.97 (C3II), 72.99 (C4I), 72.12 (C3I), 71.65 (C4III), 71.25 (C5II), 71.15 (C4IV), 
68.14 (C3III), 67.86 (C3IV), 67.83 (C2III), 67.33 (C4II), 67.02 (C2IV), 65.57 (C5IV), 64.42 (C5III), 61.14, 
61.08 (C6I, C6III), 55.73 (C2I), 27.14 (CMe3 of tert-Bu), 21.00, 20.98, 20.82, 20.70, 20.68, 20.65, 20.64, 
20.34 (Ac), 19.66 (CMe3 of tert-Bu), 16.14, 15.73 (C6
III, C6IV); HRMS (ESI) m/z = 1340.4334 [M + 








To a solution of compound 19 (314 mg, 200 μmol) and 2-(2-(2-(2-
azidoethoxy)ethoxy)ethoxy)ethanol (65 mg, 0.30 mmol) in dry CH2Cl2 (5.0 mL) was added activated 
MS4A.  The mixture was kept stirring at −50 °C for 15 min under Ar atmosphere, followed by 
addition of TMSOTf (11 μL, 59 μmol).  After stirring at −50 °C for 30 min, Et3N was added to 
terminate the reaction.  The mixture was filtered through a Celite bed, and the filtrate was washed 
successively with satd aq NaHCO3 and brine.  The organic layer was dried over MgSO4, filtered 
through a Celite bed, and concentrated under reduced pressure.  The residue was purified by silica 
gel chromatography (n-hexane/EtOAc 1:2, v/v, containing 0.5% Et3N) to afford 20 (262 mg, 159 μmol, 
80%) as colorless amorphous. 
 [α]D25 −73.6 (c 0.1, CHCl3 ); Rf 0.39 (n-hexane/EtOAc 2:3); 1H NMR (400 MHz, CDCl3, TMS): δ 
7.90–7.36 (19H, m, aromatic), 5.50 (bd, 1H, J3,4 3.8 Hz, H-4II), 5.38 (bd, 1H, J3,4 3.0 Hz, H-4III), 5.26–
5.08 (m, 7H, H-1IV, H-4IV, H-3III, H-3II, H-1I, H-5III, H-3IV), 5.02 (d, 1H, J1,2 8.5 Hz, H-1
I), 4.98–4.93 
(m, 2H, H-2IV, H-1III), 4.87 (dd, 1H, J1,2 4.0, J2,3 11.0 Hz, H-2
III), 4.78 (t, 1H, J2,3=J3,4=9.7 Hz, H-3
I), 
4.50–4.38 (m, 3H, H-5IV, H-6IIa, H-4I), 4.36–4.26 (m, 2H, H-2I, H-6IIb), 4.20 (bs, 2H, H-6Ia, H-6Ib), 
3.95–3.88 (m, 2H, H-2II, PEG), 3.82–3.78 (m, 1H, H-5II), 3.70–3.23 (m, 16H, H-5I, PEG), 2.11, 2.10, 
2.08×2, 2.07, 1.92, 1.87, 1.73 (s×8, 24H, Ac), 1.27–1.24 (m, 6H, C6III, C6IV), 1.16 (s, 9H, Me3 of tert-
Bu); 13C NMR (CDCl3, 100 MHz): δ 170.96×2, 170.88, 170.67, 170.38, 170.13, 169.86×2, 169.63, 
165.22×2 (C=O), 136.06, 135.47, 134.46, 133.88, 133.52, 132.40, 130.06, 130.01, 129.56, 128.94, 
128.73, 128.22, 127.87, 123.61 (aromatic), 99.88 (C1II), 98.50 (C1I), 97.63 (C1IV), 95.81 (C1III), 75.30 
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(C5I), 74.07 (C2II, C3II), 73.28 (C4I), 72.51 (C3I), 71.72 (C4III), 71.14 (C5II), 71.07(C4IV), 770.87, 
70.83, 70.76, 70.72, 70.66, 70.61, 70.55, 70.15, 70.10, 68.88 (PEG), 68.19 (C3III), 68.03 (C2IV), 67.75 
(C2III), 67.30 (C4II), 66.93 (C3IV), 65.41 (C5IV), 64.34 (C5III), 61.27 (C6I), 61.04 (C6II), 56.87 (C2I), 
50.80 (PEG), 27.15 (CMe3 of tert-Bu), 21.01, 20.96, 20.83, 20.70×2, 20.68×2, 20.37 (Ac), 19.61 
(CMe3 of tert-Bu), 16.14, 15.65 (C6






To a solution of compound 20 (262 mg, 159 μmol) in MeOH (5.0 mL) was added MeONa in MeOH 
solution (ca. 28 wt%; 32 μL, 159 μmol).  After stirring at rt for 2 h, DOWEX 50W-X8 (H+ form) 
was added to neutralize the reaction system, and then filtered through cotton, concentrated under 
reduced pressure to obtain the crude mixture (203 mg).  To a solution of the mixture (164 mg, 136 
μmol) in EtOH (4.0 ml) was added NH2NH2·H2O (33 μL, 681 μmol).  After stirring at 90 °C for 13 
h, the reaction mixture was concentrated under reduced pressure.  The residue was dissolved in 
pyridine (5.0 mL), followed by addition of Ac2O (192 μL, 2.04 mmol) and DMAP (8 mg, 68.0 
μmol).  After stirring at rt under dry atmosphere overnight, MeOH (1 mL) was added to quench 
excess reagents, and the mixture was concentrated with toluene under reduced pressure.  The 
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residue was dissolved in CHCl3, washed with satd aq NaHCO3 and brine.  The organic layer was 
dried over MgSO4, filtered through a Celite bed, and concentrated under reduced pressure.  The 
residue was purified by silica gel chromatography (MeOH/EtOAc, 1:30, v/v, containing 1% Et3N) to 
afford 21 (151 mg, 101 μmol, 64%) as colorless amorphous. 
[α]D25 −115.5 (c 0.24, CHCl3 ); Rf 0.51 (CHCl3/MeOH, 10:1); 1H NMR (400 MHz, CDCl3, TMS): δ 
7.76–7.70, 7.42–7.32 (m, 10H, aromatic), 6.11 (d,1H, J2,NH 8.6 Hz, NH), 5.39–5.37 (m, 2H, H-1IV, 
H-4III), 5.33–5.28 (m, 2H, H-4I, H-1III), 5.24 (dd, 1H, J2,3 11.0, J3,4 3.0 Hz, H-3III), 5.17 (bs, 1H, H-
4IV), 5.07–4.95 (m, 5H, H-1II, H-2III, H-3IV, H-2IV, H-5III), 4.92 (dd, 1H, J2,3 10.0, J3,4 3.5 Hz, H-
3II),4.61 (d, 1H, J1,2
 7.4 Hz, H-1I), 4.45 (dd, 1H, J5,6a 6.4, J6a,6b 11.5 Hz, H-6
IIa), 4.32–4.20 (m, 3H, 
H-4I, H-6IIb, H-5IV), 4.15–4.04 (m, 2H, H-6Ia, H-6Ib), 3.93-3.86 (m, 4H, H-2I, H-3I, PEG×1), 3.78-
3.59 (m, 14H, H-2II, H-5II, PEG×6), 3.42–3.39 (m, 2H, PEG×1), 3.16–3.12 (m, 1H, H-5I), 2.18, 2.14, 
2.13, 2.11, 2.05×2, 1.99, 1.96, 1.95, 1.91 (s×10, 3H×10, Ac×10), 1.17–1.06 (m, 15H, H-6IV, H-6III, 
Me3 of tert-Bu); 
13C NMR (100 MHz, CDCl3): δ 171.64, 171.37, 170.90, 170.66, 170.60×2, 170.39, 
170.24, 169.86, 169.80 (C=O), 136.05, 135.46, 133.61, 132.47, 129.89, 128.07, 127.81 (aromatic), 
101.48 (C1I), 100.56 (C1II), 96.64 (C1III), 96.09 (C1IV), 75.37 (C5I), 73.61 (C2II), 73.40 (C3II), 73.08 
(C4I), 71.79 (C4III), 71.36, 71.07 (PEG), 70.97 (C4IV), 70.94 (C5II), 70.68, 70.67, 70.55, 70.07 
(PEG), 68.19 (C3III), 68.10 (C3I, C2IV), 68.04 (C2I), 67.96 (C2III), 67.72 (C3IV), 67.33 (C4II), 65.03 
(C5IV), 64.06 (C5III), 61.36 (C6I), 61.04 (C6II), 50.78 (PEG), 27.10 (Me3 of tert-Bu), 23.48, 21.33, 




HRMS (ESI, positive ion mode) m/z = 1510.6196 [M + NH4]
+, calcd for C68H100N5O31Si1, 
1510.6172. 
 
4.17. Sodium {2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl β-D-galactopyranosyl-(1→4)-[α-L-
fucopyranosyl-(1→3)]-2-acetamido-2-deoxy-6-O-sulfonato-β-D-glucopyranoside} (3). 
To a solution of the compound 17 (30 mg, 24.9 μmol) in MeOH (3.0 mL) was added MeONa (ca. 28 
wt-%) in MeOH (2 μL, 12.4 μmol ).  After stirring at rt overnight, the reaction mixture was 
concentrated under reduced pressure.  The residue was purified by Biogel P-2 gel column eluting 
with H2O to afford 3 (13 mg, 15.6 μmol, 63%) as colorless amorphous. 
 [α]D25 −37.5 (c 0.2, MeOH); Rf 0.51(CHCl3/MeOH/H2O, 5:4:1); 1H NMR (400 MHz, CD3OD): δ 
5.04 (d, 1H, J1,2 3.9 Hz, H-1
II), 4.83–4.76 (m, 1H, H-5II), 4.59 (d, 1H, J1,2 7.6 Hz, H-1III), 4.55 (d, 1H, 
J1,2 7.7 Hz, H-1
I), 4.44 (dd, 1H, J5,6a 3.4, J6a,6b 10.8 Hz, H-6
IIIa), 4.31 (dd, 1H, J5,6b 2.5, J6a,6b 10.9 Hz, 
H-6IIIb), 3.98–3.84 (m, 5H, H-2I, H-3II, H-4I, PEG×1), 3.82 (d, 1H, J3,4 2.9 Hz, H-4III), 3.79–3.61 (m, 
18H, H-6Ia, H-6Ib, H-2II, H-3I, H-4II, H-5III, PEG×6), 3.56–3.1 (m, 2H, H-3 III, H-5I), 3.47 (dd, 1H, 
J1,2 7.6, J2,3 9.6 Hz, H-2
III), 3.42–3.38 (m, 2H, PEG×1), 1.97 (s, 3H, Ac), 1.17 (d, 3H, J5,6 6.5 Hz, H-
6II); 13C NMR (CD3OD, 100 MHz) δ 173.83 (C=O),103.61 (C1III), 102.40 (C1I), 100.15 (C1II), 76.40 
(C5I), 76.27, 75.17, 75.07, 74.80, 73.72 (C4II, C3III, C5III, C3I, C4I), 72.97 (C2III), 71.51, 71.48, 
71.44, 71.40, 71.35 (PEG), 71.15 (C3II), 71.04 (PEG), 70.11 (C4III), 69.98 (C2II), 69.94 (PEG), 67.72 
(C5II), 66.96 (C6III), 62.66 (C6I), 56.71 (C2I), 51.77 (PEG), 23.08 (Ac), 16.61 (C6II); HRMS (ESI, 
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Compound 15 (51 mg, 36.1 μmol) was suspended in dry MeOH (3.0 mL) followed by the addition of 
ca. 28 wt-% MeONa in MeOH (5 μL, 32.9 μmol).  After stirring at rt under dry atmosphere overnight, 
the reaction mixture was neutralized by the addition of Dowex 50W-X4 (H+ form), filtered through 
cotton, and concentrated under reduced pressure.  The residue dissolved in EtOH (4.0 mL) was added 
NH2NH2·H2O (10 μL, 212.8 μmol).  After stirring at 90 °C overnight, the reaction mixture was 
concentrated under reduced pressure.  To a solution of the residue in pyridine (3.0 mL) was added 
Ac2O (50 μL, 530.7 μmol).  After stirring at rt under dry atmosphere for 36 h, MeOH (1 mL) was 
added to quench excess reagents, then concentrated with toluene under reduced pressure.  The residue 
was purified by silica gel column chromatography (CH3Cl/MeOH, 1:0 to 6:1, v/v, linear gradient, Rf 
75 system).  The obtained compound was dissolved in dry THF (3.0 mL) followed by the addition of 
AcOH (3 μL, 58.6 μmol) and 1M TBAF in THF (550 μl, 550 μmol).  After stirring at rt under Ar 
atmosphere for 3 days, the reaction mixture was concentrated under reduced pressure and extracted 
with CHCl3, washed with satd aq NaHCO3 and brine.  The organic layer was dried over MgSO4, 
filtered through a Celite bed, and concentrated under reduced pressure.  The residue was roughly 
purified by silica gel column chromatography (CHCl3/Methnol, 1:0 to 6:1, v/v, linear gradient, Rf 75 
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system) to afford 16.  To a solution of 16 in MeOH (4.0 mL) was added MeONa in MeOH (ca. 28 
wt-%, 6 μL, 40.9 μmol).  After stirring at rt overnight, the reaction mixture was concentrated under 
reduced pressure.  The residue was subjected to LH-20 size-exclusion column chromatography 
eluting with H2O, and then to reversed phase column chromatography eluting with H2O/MeOH (1:0 
to 0:100, v/v, linear gradient, Rf 75 system) to afford 4 (4 mg, 5.47μmol, 15%, 5 steps) as colorless 
amorphous. 
[α]D24 −56.0 (c 0.04, MeOH); Rf 0.58 (CHCl3/MeOH/H2O, 5:4:1); 1H NMR (400 MHz, CD3OD): δ 
5.03 (d, 1H, J1,2 3.9 Hz, H-1
II), 4.86–4.81 (m, 1H, H-5II), 4.54 (d, 1H, J1,2 7.5 Hz, H-1I), 4.44 (d, 1H, 
J1,2 7.3 Hz, H-1
III), 3.95–3.84 (m, 6H, H-6IIIa, H-4I, H-2I, H-3II, PEG×1), 3.82–3.60 (m, 19H, H-4III, 
H-6Ia, H-4II, H-6IIIb, H-6Ib, H-5III, H-2II, PEG×6), 3.54–3.35 (m, 6H, H-2III, H-3III, H-3I, H-5I, 
PEG×1), 1.97 (s, 3H, Ac), 1.18 (d, 3H, J5,6 6.6 Hz, H-6
II); 13C NMR (CD3OD, 100 MHz): δ 173.90 
(C=O), 103.89 (C1III), 102.40 (C1I), 100.35 (C1II), 77.42 (C5I), 76.66 (C3I, C5III), 75.17 (C3II), 74.90 
(C3III), 73.69 (C4II), 72.75 (C2III), 71.69, 71.62, 71.54, 71.51 (PEG), 71.22 (C4I), 71.13 (PEG), 70.00 
(C4III), 69.94 (C2II), 69.90 (PEG), 67.67 (C5II), 62.77 (C6I), 61.39 (C6III), 57.38 (C2I), 51.77 (PEG), 








Compound 21 (24 mg, 16.1 μmol) was dissolved in THF (3 mL) followed by addition of AcOH (3 
μl, 64.3 μmol) and TBAF (156 μL, 156 μmol).  After stirring at rt under Ar atmosphere for 72 h, the 
reaction mixture was concentrated under reduced pressure and extracted with CHCl3, washed 
successively with satd aq NaHCO3 and brine.  The organic layer was dried over Na2SO4, filtered 
through a Celite bed, and concentrated under reduced pressure.  The residue was roughly purified 
by silica gel column chromatography eluting with CH3Cl/MeOH (1:0 to 6:1, v/v, linear gradient, Rf 
75 system).  To a solution of the obtained product in dry MeOH (3 mL) was added MeONa in 
MeOH (ca. 28 wt-%, 10 μL, 56.8 μmol).  After stirring at rt overnight, the reaction mixture was 
added DOWEX 50W-X4 (H+ form) to neutralize the reaction system, and then filtered and 
concentrated under reduced pressure.  The residue was purified by LH20 column chromatography 
eluting with MeOH to afford 5 (8 mg, 9.1 μmol, 57%, 2 steps) as colorless amorphous. 
[α]D22 −104.4 (c 0.01, MeOH ); Rf 0.53 (CHCl3/MeOH/water, 5:4:1); 1H NMR (400 MHz, CD3OD): 
δ 5.17 (d, 1H, J1,2 3.2 Hz, H-1IV), 5.03 (d, 1H, J1,2 3.9 Hz, H-1III), 4.88–4.79 (m, 1H, H-5IV), 4.54-
4.51 (m, 2H, H-1I, H-1II), 4.22–4.16 (m, 1H, H-5III), 3.95–3.61 (m, 29H, PEG×6, H-2I, H-3I, H-4I, H-
6Ia, H-6Ib, H-2II, H-3II, H-4II, H-5II, H-6IIa, H-6IIb, H-2III, H-3III, H-4III, H-2IV, H-3IV, H-4IV), 3.47–
3.43 (m, 1H, H-5I), 3.39–3.35 (m, 2H, PEG×1), 1.97 (s, 3H, Ac), 1.26–1.21 (m, 6H, H-6III, H-6IV); 
13C NMR (CDCl3, 100 MHz): δ 173.89 (C=O), 102.53, 102.21 (C1I, C1II), 102.14 (C1IV), 100.36 
(C1III), 79.45, 77.45, 76.72, 76.64, 76.52, 75.30, 74.46, 73.71, 73.67, 71.87, 71.68, 71.60, 71.53, 
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71.25, 71.13, 70.79, 70.13, 69.96, 69.93 (C5I, C4I, C5II, C3I, C4II, C2II, C3II, C4II, C2III, C3III, C2IV, 
C3IV, C4IV, PEG), 68.28 (C5III), 67.65 (C5IV), 62.94, 62.71 (C6I, C6II), 57.32 (C2I), 51.78 (PEG), 
23.12 (Ac), 16.86, 16.80 (C6III, C6IV); HRMS (ESI, positive ion mode) m/z = 899.3592 [M + Na]+, 
calcd for C34H60N4O22Na, 899.3597. 
 
4.20. A typical procedure for synchronous synthesis of 10 and 11. 
Compound 2 (100 mg, 96.3 μmol) was added to a solution of 9 (90 mg, 170.9 μmol) in anhydrous 
CH2Cl2 (1.0 mL), and then diluted with anhydrous Et2O (2.0 mL).  The mixture was kept stirring at 
rt for 30 min under Ar atmosphere in the presence of activated MSAW 300 (100 mg).  N-
Iodosuccinimide (55 mg, 244.5 μmol) was added to the mixture, and then it was cooled down to 
−40 °C under Ar atmosphere.  Triflic acid (1.7 μL, 19.3 μmol) in anhydrous Et2O (100 μL) was 
injected to the mixture.  After stirring for 1 h, excess amount of Et3N was added to terminate the 
reaction.  The mixture was filtered through a Celite bed, diluted with CHCl3, washed successively 
with 5% aq Na2S2O3, satd aq NaHCO3 and brine.  The organic layer was dried over MgSO4, filtered 
through a Celite bed, and concentrated under reduced pressure.  The residue was subjected to silica 
gel column chromatography (n-hexane/EtOAc, 1:0 to 0:1, v/v, linear gradient, Rf75 system), 
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Supplementary data 
1H, H,H-COSY and 13C NMR spectra of compounds 2–5, 7–8, 10–21 are provided as 
Supplementary data online version. 
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